Mueller Water Products, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Mueller Water Products, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.43B | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $1.31B | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $1.28B | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $1.25B | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $1.11B | Dec 14, 2023 |
| FY2020 | Sep 30, 2020 | $265.30M | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $228.50M | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $257.70M | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $212.60M | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $266.90M | Nov 19, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $226.90M | Nov 21, 2017 |
| FY2017 | Jun 30, 2017 | $232.20M | Nov 21, 2017 |
| FY2017 | Mar 31, 2017 | $199.70M | Nov 21, 2017 |
| FY2017 | Dec 31, 2016 | $167.20M | Nov 21, 2017 |
| FY2017 | Sep 30, 2016 | $215.60M | Nov 21, 2017 |
| FY2017 | Jun 30, 2016 | $224.70M | Nov 21, 2017 |
| FY2017 | Mar 31, 2016 | $197.20M | Nov 21, 2017 |
| FY2017 | Dec 31, 2015 | $163.10M | Nov 21, 2017 |
| FY2016 | Sep 30, 2015 | $311.40M | Nov 22, 2016 |
| FY2016 | Jun 30, 2015 | $301.00M | Nov 22, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $516.70M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $459.00M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $379.50M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $364.30M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $358.50M | Dec 14, 2023 |
| FY2020 | Sep 30, 2020 | $93.90M | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $75.70M | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $86.00M | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $72.60M | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $88.80M | Nov 19, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $191.70M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $115.90M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $85.50M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $76.60M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $70.40M | Dec 14, 2023 |
| FY2020 | Sep 30, 2020 | $26.70M | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $11.20M | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $23.80M | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $10.30M | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $40.20M | Nov 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $260.60M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $181.70M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $127.40M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $111.60M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $131.70M | Dec 14, 2023 |
| FY2020 | Sep 30, 2020 | $40.70M | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $20.00M | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $35.80M | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $20.30M | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $39.00M | Nov 19, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $19.90M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $20.50M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $25.90M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $24.50M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $17.10M | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | $15.00M | Nov 18, 2022 |
| FY2021 | Sep 30, 2019 | $14.30M | Nov 19, 2021 |
| FY2020 | Sep 30, 2018 | $11.60M | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $12.10M | Nov 20, 2019 |
| FY2018 | Sep 30, 2016 | $9.90M | Nov 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $247.30M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $245.20M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $241.90M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $238.70M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $218.80M | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | $198.40M | Nov 18, 2022 |
| FY2021 | Sep 30, 2019 | $182.70M | Nov 19, 2021 |
| FY2020 | Sep 30, 2018 | $166.70M | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $155.40M | Nov 20, 2019 |
| FY2018 | Sep 30, 2016 | $149.50M | Nov 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $219.30M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $238.80M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $109.00M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $52.30M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $156.70M | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | $140.30M | Nov 18, 2022 |
| FY2021 | Sep 30, 2019 | $92.50M | Nov 19, 2021 |
| FY2020 | Sep 30, 2018 | $133.10M | Nov 19, 2020 |
| FY2011 | Sep 30, 2011 | $40.10M | Nov 29, 2011 |
| FY2011 | Sep 30, 2010 | $63.00M | Nov 29, 2011 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Sep 30, 2013 | $35.60M | Nov 22, 2013 |
| FY2012 | Sep 30, 2012 | $31.40M | Nov 29, 2012 |
| FY2012 | Jun 30, 2012 | $15.90M | Nov 29, 2012 |
| FY2011 | Sep 30, 2011 | $31.50M | Nov 29, 2011 |
| FY2012 | Mar 31, 2011 | $10.00M | Nov 29, 2012 |
| FY2011 | Sep 30, 2010 | $32.80M | Nov 29, 2011 |
| FY2011 | Sep 30, 2009 | $39.70M | Nov 29, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.84B | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $1.64B | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $1.51B | Nov 20, 2024 |
| FY2022 | Sep 30, 2022 | $1.50B | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | $1.52B | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $1.40B | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $1.34B | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $1.29B | Nov 20, 2019 |
| FY2018 | Sep 30, 2017 | $1.26B | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $1.28B | Nov 21, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $857.20M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $825.80M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $793.50M | Nov 20, 2024 |
| FY2022 | Sep 30, 2022 | $828.80M | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | $823.10M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $754.30M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $745.00M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $727.10M | Nov 20, 2019 |
| FY2018 | Sep 30, 2017 | $768.80M | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $861.10M | Nov 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $981.70M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $810.10M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $711.50M | Nov 19, 2025 |
| FY2025 | Sep 30, 2022 | $669.30M | Nov 19, 2025 |
| FY2024 | Sep 30, 2021 | $694.90M | Nov 20, 2024 |
| FY2021 | Sep 30, 2020 | $640.70M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $590.10M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $563.30M | Nov 20, 2019 |
| FY2018 | Sep 30, 2017 | $488.40M | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $418.30M | Nov 21, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $89.20M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $80.70M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $93.70M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $98.60M | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | $115.10M | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | $99.80M | Nov 18, 2022 |
| FY2021 | Sep 30, 2019 | $95.70M | Nov 19, 2021 |
| FY2020 | Sep 30, 2018 | $12.10M | Nov 19, 2020 |
| FY2018 | Sep 30, 2017 | $12.90M | Nov 21, 2018 |
| FY2019 | Feb 15, 2017 | $7.20M | Nov 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($174.20M) | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | ($365.90M) | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | ($481.80M) | Nov 20, 2024 |
| FY2022 | Sep 30, 2022 | ($567.30M) | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | ($643.90M) | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | ($714.20M) | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | ($786.20M) | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | ($850.00M) | Nov 20, 2019 |
| FY2018 | Sep 30, 2017 | ($955.60M) | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | ($1.08B) | Nov 21, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Sep 30, 2021 | $227.50M | Nov 19, 2021 |
| FY2021 | Sep 30, 2020 | $208.90M | Nov 19, 2021 |
| FY2021 | Sep 30, 2019 | $176.70M | Nov 19, 2021 |
| FY2021 | Sep 30, 2018 | $347.10M | Nov 19, 2021 |
| FY2020 | Sep 30, 2017 | $361.70M | Nov 19, 2020 |
| FY2019 | Sep 30, 2016 | $195.00M | Nov 20, 2019 |
| FY2018 | Sep 30, 2015 | $113.10M | Nov 21, 2018 |
| FY2017 | Sep 30, 2014 | $161.10M | Nov 21, 2017 |
| FY2016 | Sep 30, 2013 | $123.60M | Nov 22, 2016 |
| FY2015 | Sep 30, 2012 | $83.00M | Nov 24, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $451.60M | Nov 18, 2022 |
| FY2022 | Sep 30, 2021 | $452.20M | Nov 18, 2022 |
| FY2021 | Sep 30, 2020 | $452.50M | Nov 19, 2021 |
| FY2020 | Sep 30, 2019 | $452.10M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $451.60M | Nov 20, 2019 |
| FY2018 | Sep 30, 2017 | $486.50M | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $490.70M | Nov 21, 2017 |
| FY2016 | Sep 30, 2015 | $496.40M | Nov 22, 2016 |
| FY2015 | Sep 30, 2014 | $545.60M | Nov 24, 2015 |
| FY2014 | Sep 30, 2013 | $600.80M | Nov 26, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 1 | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | 0 | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Dec 14, 2023 |
| FY2020 | Sep 30, 2020 | 0 | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 19, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 1 | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | 0 | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Nov 20, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Dec 14, 2023 |
| FY2020 | Sep 30, 2020 | 0 | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 19, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 156.33M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | 156.23M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | 155.87M | Nov 19, 2025 |
| FY2025 | Sep 30, 2022 | 155.84M | Nov 19, 2025 |
| FY2024 | Sep 30, 2021 | 157.96M | Nov 20, 2024 |
| FY2022 | Sep 30, 2020 | 158.06M | Dec 14, 2023 |
| FY2022 | Sep 30, 2019 | 157.46M | Nov 18, 2022 |
| FY2021 | Sep 30, 2018 | 157.33M | Nov 19, 2021 |
| FY2020 | Sep 30, 2017 | 158.59M | Nov 19, 2020 |
| FY2019 | Sep 30, 2016 | 161.69M | Nov 20, 2019 |